Concepedia
Statistics
Publications
19
Citations
1.8K
H-Index
16
Active since
2010
Affiliations
United States Food and Drug Administration(Current)
Center for Drug Evaluation and Research
Center for Devices and Radiological Health
National Cancer Institute
University of Pennsylvania
Yutao Gong is an author at United States Food and Drug Administration specializing in medicine, oncology, and cancer therapeutics.
Top concepts
MedicineOncologyCancer TherapyRadiation OncologyCancer ResearchClinical TrialsHealthPathologyPharmacotherapyMolecular Oncology
Publications per year
2010–2021
Phase transitions in biogenic amorphous calcium carbonate
Yutao Gong, Christopher E. Killian, Ian C. Olson et al. · Proceedings of the National Academy of Sciences · 2012 · 289 citations · Full text
Phase Transitions, Engineering, Biochemistry +11
Prognostic Value of the Lung Immune Prognostic Index for Patients Treated for Metastatic Non–Small Cell Lung Cancer
Dickran Kazandjian, Yutao Gong, Patricia Keegan et al. · JAMA Oncology · 2019 · 249 citations · Full text
FDA Approval Summary: Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma
Elaine Chang, Chana Weinstock, Lijun Zhang et al. · Clinical Cancer Research · 2020 · 173 citations · Full text
Peripheral Neuropathy, Urology, Seattle Genetics +14
FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer
Shaily Arora, Sanjeeve Balasubramaniam, Hui Zhang et al. · The Oncologist · 2020 · 171 citations · Full text
FDA Approval Summary: Atezolizumab Plus Paclitaxel Protein-bound for the Treatment of Patients with Advanced or Metastatic TNBC Whose Tumors Express PD-L1
Preeti Narayan, Sakar Wahby, Jennifer Gao et al. · Clinical Cancer Research · 2020 · 164 citations
Breast Oncology, Immunology, Pathology +17
1–5 of 19